Literature DB >> 1619632

Detection and characterisation of an overmodified type III collagen by analysis of non-cutaneous connective tissues in a patient with Ehlers-Danlos syndrome IV.

L Nuytinck1, P Narcisi, A Nicholls, J P Renard, F M Pope, A De Paepe.   

Abstract

The clinical and biochemical observations in a patient with a mild form of Ehlers-Danlos syndrome (EDS) type IV are described. The patient's skin fibroblasts produced markedly diminished amounts of type III collagen. SDS-polyacrylamide gel electrophoresis of collagens produced by cells obtained from other, non-cutaneous tissues showed two forms of collagen alpha 1(III) chains, a normal and a slow migrating, mutant form. Further analysis confirmed that the type III collagen molecules containing mutant alpha chains which were overmodified had a lower thermal stability and were poorly secreted into the extracellular medium. The protein defect was mapped by in situ cyanogen bromide digestion and was located in alpha 1(III) CB9, the C-terminal peptide of the collagen triple helix. This study shows that non-cutaneous connective tissues can be a useful source for the study of type III collagen defects in patients with EDS type IV.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1619632      PMCID: PMC1015985          DOI: 10.1136/jmg.29.6.375

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  25 in total

1.  Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography.

Authors:  R A Laskey; A D Mills
Journal:  Eur J Biochem       Date:  1975-08-15

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 3.  Heritable diseases of collagen.

Authors:  D J Prockop; K I Kivirikko
Journal:  N Engl J Med       Date:  1984-08-09       Impact factor: 91.245

4.  The estimation of two collagens from human dermis by interrupted gel electrophoresis.

Authors:  B Sykes; B Puddle; M Francis; R Smith
Journal:  Biochem Biophys Res Commun       Date:  1976-10-18       Impact factor: 3.575

5.  Altered secretion of type III procollagen in a form of type IV Ehlers-Danlos syndrome. Biochemical studies in cultured fibroblasts.

Authors:  P H Byers; K A Holbrook; G S Barsh; L T Smith; P Bornstein
Journal:  Lab Invest       Date:  1981-04       Impact factor: 5.662

6.  Proteolytic enzymes as probes for the triple-helical conformation of procollagen.

Authors:  P Bruckner; D J Prockop
Journal:  Anal Biochem       Date:  1981-01-15       Impact factor: 3.365

7.  Clinical and ultrastructural heterogeneity of type IV Ehlers-Danlos syndrome.

Authors:  P H Byers; K A Holbrook; B McGillivray; P M MacLeod; R B Lowry
Journal:  Hum Genet       Date:  1979-03-12       Impact factor: 4.132

8.  Characterisation of a glycine to valine substitution at amino acid position 910 of the triple helical region of type III collagen in a patient with Ehlers-Danlos syndrome type IV.

Authors:  A J Richards; J C Lloyd; P N Ward; A De Paepe; P Narcisi; F M Pope
Journal:  J Med Genet       Date:  1991-07       Impact factor: 6.318

9.  Subtle structural alterations in the chains of type I procollagen produce osteogenesis imperfecta type II.

Authors:  J Bonadio; P H Byers
Journal:  Nature       Date:  1985 Jul 25-31       Impact factor: 49.962

10.  Patients with Ehlers-Danlos syndrome type IV lack type III collagen.

Authors:  F M Pope; G R Martin; J R Lichtenstein; R Penttinen; B Gerson; D W Rowe; V A McKusick
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

View more
  8 in total

Review 1.  Spontaneous common iliac arteries rupture in Ehlers-Danlos syndrome type IV: report of two cases and review of the literature.

Authors:  K Habib; M A Memon; D A Reid; B J Fairbrother
Journal:  Ann R Coll Surg Engl       Date:  2001-03       Impact factor: 1.891

2.  Substitution of glycine-661 by serine in the alpha1(I) and alpha2(I) chains of type I collagen results in different clinical and biochemical phenotypes.

Authors:  L Nuytinck; R Dalgleish; L Spotila; J P Renard; N Van Regemorter; A De Paepe
Journal:  Hum Genet       Date:  1996-03       Impact factor: 4.132

Review 3.  Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases.

Authors:  Helena Kuivaniemi; Gerard Tromp
Journal:  Gene       Date:  2019-05-07       Impact factor: 3.688

4.  The substitution of glycine 661 by arginine in type III collagen produces mutant molecules with different thermal stabilities and causes Ehlers-Danlos syndrome type IV.

Authors:  A Richards; P Narcisi; J Lloyd; C Ferguson; F M Pope
Journal:  J Med Genet       Date:  1993-08       Impact factor: 6.318

Review 5.  Four decades in the making: Collagen III and mechanisms of vascular Ehlers Danlos Syndrome.

Authors:  Ramla Omar; Fransiska Malfait; Tom Van Agtmael
Journal:  Matrix Biol Plus       Date:  2021-11-09

6.  Targeted next-generation sequencing makes new molecular diagnoses and expands genotype-phenotype relationship in Ehlers-Danlos syndrome.

Authors:  Ruwan A Weerakkody; Jana Vandrovcova; Christina Kanonidou; Michael Mueller; Piyush Gampawar; Yousef Ibrahim; Penny Norsworthy; Jennifer Biggs; Abdulshakur Abdullah; David Ross; Holly A Black; David Ferguson; Nicholas J Cheshire; Hanadi Kazkaz; Rodney Grahame; Neeti Ghali; Anthony Vandersteen; F Michael Pope; Timothy J Aitman
Journal:  Genet Med       Date:  2016-03-24       Impact factor: 8.822

7.  Expanding the clinical and mutational spectrum of the Ehlers-Danlos syndrome, dermatosparaxis type.

Authors:  Tim Van Damme; Alain Colige; Delfien Syx; Cecilia Giunta; Uschi Lindert; Marianne Rohrbach; Omid Aryani; Yasemin Alanay; Pelin Özlem Simsek-Kiper; Hester Y Kroes; Koen Devriendt; Marc Thiry; Sofie Symoens; Anne De Paepe; Fransiska Malfait
Journal:  Genet Med       Date:  2016-01-14       Impact factor: 8.822

8.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.